XT
KYTX icon

XTX Topco’s Kyverna Therapeutics KYTX Stock Holding History

XTX Topco’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195K Buy
+21,898
New +$194K ﹤0.01% 3269
2026
Q1 		– Sell
-23,282
Closed -$219K – 4486
2025
Q4 		$219K Sell
23,282
-25,825
-53% -$192K 0.01% 2330
2025
Q3 		$295K Buy
49,107
+14,168
+41% +$56.6K 0.02% 1513
2025
Q2 		$107K Buy
+34,939
New +$86.4K ﹤0.01% 1873
2025
Q1 		– Sell
-43,949
Closed -$164K – 3221
2024
Q4 		$164K Sell
43,949
-8,843
-17% -$42.4K 0.01% 1628
2024
Q3 		$258K Sell
52,792
-30,494
-37% -$235K 0.02% 1287
2024
Q2 		$625K Buy
+83,286
New +$1.27M 0.05% 549

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

XTX Topco's KYTX Position: Q2 2026 in Review

XTX Topco opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 21,898 shares worth $195K. The stake represents ﹤0.01% of the portfolio and ranks #3269 among its holdings. This is a return to the name: XTX Topco previously reported a position in KYTX as recently as Q4 2025.

XTX Topco first reported a position in KYTX in Q2 2024 and has held it in 7 quarters since. The position peaked at $625K in Q2 2024. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • XTX Topco held 21,898 shares of Kyverna Therapeutics worth $195K as of Q2 2026.
  • Kyverna Therapeutics was a new XTX Topco position in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3269 holding.
  • XTX Topco first reported a position in Kyverna Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • XTX Topco's Kyverna Therapeutics position peaked at $625K in Q2 2024.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.